Si-Bone Inc. (SIBN)
NASDAQ
Real-time Data
01:30 PM
Day's Range
17.5652 wk Range
11.48Overview - SIBN - Si-Bone Inc.
Key Statistics
Valuation
Enterprise Value
769.47M
P/E (Trailing)
‪-44.48‬
P/E (Forward)
‪-59.07‬
PEG Ratio
‪1.24‬
Price / Sales (TTM)
‪4.10‬
Price / Book
‪4.79‬
EV / EBITDA
‪-67.94‬
Profitability
Gross Margin
‪79.53%‬
Profit Margin
‪-6.85%‬
Operating Margin
‪-8.58%‬
Return on Assets
‪-4.62%‬
Return on Equity
‪-8.29%‬
Ownership
Shares Outstanding
44.69M
Float
39.94M
Short % of Shares Outstanding
‪13.21%‬
Held by Insiders
‪3.29%‬
Held by Institutions
‪109.73%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪17.52‬
200-Day Avg
‪16.29‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - SIBN - Si-Bone Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - SIBN - Si-Bone Inc.
About
Si-Bone Inc. is a prominent medical device company specializing in the development and commercialization of minimally invasive surgical implants for the treatment of sacroiliac joint dysfunction. Known for its iFuse Implant System, the company's primary product aims to alleviate pain and improve mobility in patients…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
